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Objective: In obsessive-compulsive disorder (OCD), symmetry-related symptoms may be important.
Although clinical correlates of symmetry-related symptoms have been identified in OCD, few data exist
on genetic associations. Animal studies indicate involvement of dopamine in symmetry-related
behavior, suggesting this may be relevant to analogous symptoms in OCD. Alterations in dopamine
may also reflect environmental influences. However, the association of symmetry-related symptoma-
tology, early adversity, and polymorphisms in dopaminergic genes has not been investigated in OCD.
Methods: Clinical information and polymorphisms in key dopaminergic genes were compared
between OCD patients with primary symmetry symptoms and those without.
Results: OCD patients with primary symmetry symptoms comprised 46.6% (n=210) of the sample
(n=451), and were older (po 0.01), had longer illness duration (po 0.01), higher OCD severity scores
(p = 0.01), and greater comorbidity (p o 0.01) than those without. In Caucasians (n=343), genotype
frequency differed significantly between groups for ANKK1 rs1800497, with more OCD patients with
symmetry symptoms being homozygous for the A2 (CC) genotype (w2 = 7.296; p = 0.026).
Conclusion: Symmetry symptoms have some distinct clinical features and may represent a marker of
severity in OCD. However, clinical associations, in combination with the association found with the
ANKK1 rs1800497 A2 variant, suggest that primary symmetry symptoms may represent a distinctive
clinical and psychobiological profile.
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Introduction
There are many definitions of symmetry, which vary
depending on context. Typically, however, symmetry refers
to a characteristic feature of an object where one half
appears to mirror the other half. Symmetry may also relate
to living organisms, including humans and animals. The
body of most multicellular organisms exhibits some form of
symmetry. In humans, for example, facial symmetry
generally is one of a number of traits associated with
health and beauty. Indeed, some literature suggests that
symmetry is an important indicator of ‘‘freedom from
disease, and worthiness for mating’’1 and one of the most
important determinants of attractiveness in humans.2
However, excessive or irrational concern with or
preference for symmetry may also be indicative of
psychopathology. For example, obsessions with symmetry
and related compulsions, such as ordering and arranging,
have received increased empirical attention in recent
years. Analyses of obsessive-compulsive symptomatology
in obsessive-compulsive disorder (OCD) have consistently
identified a factor characterized by symmetry concerns and
related rituals.3,4 In OCD, symmetry obsessions are char-
acterized by the need for things to be perfect, exact or
‘‘just right,’’ symmetrical, or correctly aligned, and related
compulsions include ordering and arranging, evening up or
aligning things, and touching or tapping.
Symmetry symptoms have previously been found to
occur more frequently in men and to be associated with
earlier age of onset of OCD.5,6 Symmetry in OCD has
also been associated with poorer prognosis, including
increased comorbidity with a range of psychiatric condi-
tions, such as Tourette’s disorder4,5; decreased level of
functioning; and poorer response to treatment.7,8 In a
prospective follow-up study of treated OCD patients,
symmetry/ordering was the only symptom dimension from
the Dimensional Yale-Brown Obsessive-Compulsive
Scale (DY-BOCS) that was more common among those
who attempted or committed suicide, and it was indepen-
dently associated with suicidal behaviors.9
In humans, it has also been argued that symmetry or
symmetry-related behaviors may have specific psycho-
biologic and evolutionary underpinnings.10 Interestingly,
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familial OCD (compared to sporadic OCD) has also been
found to be associated with increased compulsions,
particularly ordering, i.e., one aspect of the symmetry
symptom dimension.11 Animal studies have indicated that
the dopamine neurotransmitter system is involved in
symmetry.12 This is consistent with a range of data
pointing to an important role for the dopamine system in
OCD.13 Alterations in the dopaminergic system may
reflect the influence of particular environmental factors
(e.g., exposure to stress or adversity)14 or particular
genetic factors (e.g., functional variants in the dopamine
system).15 However, although OCD is considered a poly-
genic disorder,16 the particular association of symmetry-
related symptomatology, early adversity, and selected
polymorphisms in dopaminergic genes has, to our knowl-
edge, not been investigated in this condition.
Here, we aimed to investigate the clinical and genetic
associations of symmetry symptoms in OCD, with a
particular focus on associations of these symptoms with
early adversity and with variants in the dopamine system.
We hypothesized that OCD patients with symmetry symp-
toms would have greater illness severity (i.e., increased
OCD severity, psychiatric comorbidity and childhood trauma,
and decreased level of functioning and longer duration of
illness) and that there would be evidence for significant
associations between symmetry and early adversity, and
between symmetry and polymorphisms in candidate dopa-
minergic genes.
Materials and methods
Subjects
Four hundred and fifty-one patients with primary OCD (221
male; 230 female) took part in the study. All patients met
DSM-IV-TR criteria for current OCD17 on the Structured
Clinical Interview for the Diagnosis of Axis I Disorders -
Patient Version (SCID-I/P).18 A psychologist, psychiatrist,
or psychiatric nurse interviewed the participants. The
exclusion criteria were history of psychosis, inadequate
understanding of the goals and implications of study
participation, and unwillingness to provide consent after
being presented with the study information. The Ethics
Committee of the University of Stellenbosch gave approval
for the study to be conducted, and all participants gave
informed written consent to participate after the risks and
benefits of participation had been fully explained.
Data collection
Demographic data (including age and gender) were
collated. The nature, prominence, and severity of OCD
symptoms were assessed using the DY-BOCS and/or the
Yale-Brown Obsessive-Compulsive Checklist and Sever-
ity Scale (Y-BOCS).19 Data collection at our site has been
ongoing for a number of years. Initially, before the DY-
BOCS was available, the Y-BOCS checklist was used to
assess for the presence/absence of specific symptoms
and whether these particular symptoms were primary.
More recently, the DY-BOCS was added to the assess-
ment battery, which led to a situation in which we have
Y-BOCS data for some patients, DY-BOCS data for
others, and data from both scales for the rest.
The SCID-I/P was used to assess for DSM axis I
disorders,18 and the SCID-II/P to assess for selected
personality disorders. The Structured Clinical Interview for
the Diagnosis of OCD Spectrum Disorders (SCID-OCSD)
was administered to assess for OCD-related disorders.20
Age of onset and duration of OCD were noted. Patients
also completed a disability profile (DP),21 which was used to
assess lifetime impairment in eight domains (alpha coeffi-
cients: 0.87 for current rating, 0.90 for lifetime rating) due to
OCD. Each item is rated separately for current and for
lifetime disability on a five-point, descriptively anchored scale
ranging from 0 (no impairment) to 4 (severe impairment).
The Childhood Trauma Questionnaire (CTQ), a self-
report scale used to assess a broad range of traumatic
experiences in childhood,22 was completed by all partici-
pants. This questionnaire comprises 28 items that fall into
five categories/subscales: emotional abuse, physical
abuse, sexual abuse, emotional neglect, and physical
neglect. The reliability and validity of the CTQ have been
well researched.22
Genotyping
DNA, extracted from venous blood (10-30 mL) in a
Caucasian subset (n=343) of participants with current
primary symmetry-related obsessions and/or compul-
sions (n=156 [45.5%]) and those without (n=187
[54.5%]), was genotyped to investigate polymorphisms
in key dopaminergic genes. For the purposes of this
study, South African Caucasians were classified as those
participants who were white and had self-reported home
languages of English and/or Afrikaans. The polymorph-
isms investigated were: a 48 base-pair (bp) variable
number of tandem repeats (VNTR) in the third exon of the
dopamine receptor 4 (DRD4), a 40-bp VNTR in the 30
untranslated region of the dopamine transporter (DAT),
the catechol-O-methyl transferase (COMT) Val158Met
polymorphism, the monoamine oxidase A (MAOA)
C1460T/EcoRV polymorphism, the DRD3 Ser9Gly poly-
morphism (rs6280), the rs4532 polymorphism in the
dopamine receptor 1 (DRD1) gene, and the TaqI A
(rs1800497) polymorphism located downstream of the
DRD2 gene, within the gene encoding ankyrin repeat and
kinase containing domain 1 (ANKK1). There is evidence
to suggest that these genes are directly involved with
dopamine regulation in multiple brain regions, and are
implicated in the pathogenesis of OCD.16 Previously
described genotyping protocols23,24 were followed.
Statistical analysis
The sample was divided into two groups: those with primary
symmetry concerns and/or compulsions and those without
these symptoms. To determine whether symmetry and
related symptomatology were primary, we employed the
following method: Four Y-BOCS items specifically refer to
this symptom dimension, and those patients who indicated
that these symptoms were primary were allocated to the
group with primary symmetry symptomatology. In terms of
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the DY-BOCS, symmetry symptoms were considered
primary if the chronological severity item on the scale was
marked as either 1 or 2, indicating that the patient considered
this particular symptom dimension the most (or second most)
prominent of all their OCD symptoms.
The 40-bp VNTR in DAT and 48-bp VNTR in DRD4
presented a unique challenge within the statistical analyses
due to the possibly of more than three genotype options
within the cohort. All possible combinations were considered
(DRD4 = 13 possible combinations; DAT = six possible
combinations). This challenge was addressed by the Multiple
Testing Procedure in SAS, which handles data arising from a
multivariate one-way analysis of variance (ANOVA) model
with discrete response variables. The requested adjusted
p-values are based on the idea of Fisher’s combination test.
This Fisher’s combination option requests adjusted p-values
by using closed tests, based on the idea of Fisher’s
combination test (a joint test of any set of S hypotheses
with p-values using the chi-square statistic with 2S degrees of
freedom). Furthermore, as the MAOA gene lies on the
X chromosome, genetic association analyses for polymorph-
isms within this gene were performed on a stratified cohort
(males and females separately).
It has been argued that correction for population
structure is necessary, given that spurious association
may result if the genetic background of the subpopula-
tions comprising the sample under investigation differ.25
The MAOA and DAT genes necessitated adjustment for
home language with the group comparisons (previous
work by our group found that using language as a proxy
for population structure served well in statistically correct-
ing for this factor, if applicable26).
Clinical and genetic data were compared between patients
with primary symmetry concerns and/or compulsions and
those without these symptoms by using ANOVAs and
chi-square tests as appropriate.
P-values o 0.05 were considered significant.
Results
Demographics
There were 451 participants with a primary diagnosis of
OCD; 210 (46.6%) of those reported current primary
symmetry obsessions and related compulsions, including
ordering, counting and arranging, and 241 (53.4%) were
free of these symptoms. The two groups were similar in
gender distribution but differed significantly in terms of their
age at the time of assessment (Table 1). Patients reporting
current primary symmetry-related symptoms were signifi-
cantly older than those without symmetry concerns.
Clinical characteristics
The two groups differed significantly on a number of
clinical aspects (Table 2). Those with symmetry sympto-
matology had significantly higher OCD severity scores
(p = 0.01) and reported longer illness duration (po 0.01)
than those without.
Presence of OCD symmetry symptomatology was
also significantly associated with lifetime comorbid
panic disorder, posttraumatic stress disorder (PTSD),
and obsessive-compulsive personality disorder (OCPD)
(p o 0.01; Table 3).
Genetics
COMT (rs4680),DRD1 (rs4532),DRD2/ANKK1 (rs1800497),
DRD3 (rs6280), the 40-bp (DAT) and 48-bp (DRD4)
VNTRs, and MAOA (rs1137070) were assessed for
significant associations with primary symmetry symp-
toms reported by Caucasian patients with OCD.
In this Caucasian subset, genotype frequency differed
significantly between OCD patients with primary symmetry
symptomatology and those without, for ANKK1 rs1800497,
Table 1 Demographic data in OCD patients with and without primary symmetry symptomatology
Variable
OCD with symmetry-related
symptoms (n=210)
OCD without symmetry-related
symptoms (n=241) Statistics p-value
Gender
Male 96 (45.7) 125 (51.9) w2 = 1.701 NS
Female 114 (54.3) 116 (48.1)
Age (years) 34.5613.0 29.7612.2 F = 1.395 p o 0.01*
Data presented as n (%) or mean 6 standard deviation.
NS = not significant; OCD = obsessive-compulsive disorder.
*Mann-Whitney U test.
Table 2 Clinical data in OCD patients with and without primary symmetry symptomatology
Variable
OCD with symmetry-related
symptoms (n=210)
OCD without symmetry-related
symptoms (n=241) p-value*
Age at OCD onset (years) 16.9610.8 16.668.8 NS
OCD severity (Y-BOCS total) 2167 19.266.9 p = 0.01
DP total 11.165.3 10.565.3 NS
CTQ total 42.4616.9 41.6614.7 NS
Illness duration (years) 17.5612 13.01611.5 p o 0.01
Data presented as mean 6 standard deviation.
CTQ = Childhood Trauma Questionnaire; DP = disability profile; NS = not significant; OCD = obsessive-compulsive disorder; Y-BOCS =
Yale-Brown Obsessive-Compulsive Checklist and Severity Scale.
*Mann-Whitney U test.
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previously known as the DRD2 TaqI A polymorphism (w2 =
7.296; p = 0.026), with more OCD patients with symmetry
symptoms being homozygous for the A2 (CC) genotype.
Furthermore, the frequency of the A2 (C) alleles was
significantly increased in patients with primary symmetry
symptoms compared to those without (w2 = 4.1; p = 0.043)
(Table 4).
We found no statistically significant associations of
COMT (rs4680), DRD1 (rs4532), or DRD3 (rs6280) with
symmetry symptomatology in our sample. Similarly,
symmetry symptoms were not significantly associated
with MAOA (rs1137070) (stratified for gender) (Table 5).
Statistical significance was not observed for either the
40-bp (DAT) or the 48-bp (DRD4) VNTRs (p = 0.65 and
0.19, respectively) (Table 6). Due to the multiple allelic
combinations observed for the VNTRs, multiple testing
was corrected for and permutation testing performed. The
results indicate that none of the observed allelic combina-
tions were associated with symmetry symptomatology in
patients with OCD.
Population substructure using language as a proxy did
not significantly influence the results reported herein.
Assuming a maximum false-positive of 3 for the
polymorphisms investigated for a relative genetic risk of
Table 3 Lifetime comorbidity data in OCD patients with and without primary symmetry symptomatology
Comorbid disorder
With symmetry-related
symptoms (n=208,
except where indicated)
Without symmetry-related
symptoms (n=238,
except where indicated) Statistics
Major depressive disorder 127 (61.1) 159 (66.8) w2(1) = 1.593, p = NS
Dysthymic disorder 40 (19.2) 40 (16.8) w2(1) = 0.442, p = NS
Bipolar disorder 8 (3.8) 7 (2.9) w2(1) = 0.279, p = NS
Panic disorder (with/without agoraphobia) 30 (14.4) 15 (6.3) w2(1) = 8.138, p = 0.004
Social anxiety disorder 25 (12) 16 (6.7) w2(1) = 3.734, p = NS
Specific phobia 24 (11.5) 34 (14.3) w2(1) = 0.745, p = NS
Generalized anxiety disorder 25 (12) 25 (10.5) w2(1) = 0.255, p = NS
Posttraumatic stress disorder 15 (7.2) 4 (1.7) w2(1) = 8.706, p = 0.003
Alcohol abuse 15 (7.2) 11 (4.6) w2(1) = 1.354, p = NS
Alcohol dependence 8 (3.8) 4 (1.7) w2(1) = 2.006, p = NS
Substance abuse 6 (2,9) 5 (2.1) w2(1) = 0.283, p = NS
Substance dependence 4 (1.9) 7 (2.9) w2(1) = 0.486, p = NS
Hypochondriasis 6 (2.9) 4 (1.7) w2(1) = 0.734, p = NS
Body dysmorphic disorder 15 (7.2) 15 (6.3) w2(1) = 0.146, p = NS
Anorexia nervosa 11 (5.3) 12 (5) w2(1) = 0.014, p = NS
Bulimia nervosa 12 (5.8) 12 (5) w2(1) = 0.115, p = NS
Binge-eating disorder 5 (2.4) 3 (1.3) w2(1) = 0.826, p = NS
Tourette’s disorder 4 (1.9) 5 (2.1) w2(1) = 0.018, p = NS
Tic disorder 20 of 204 (9.8) 26 of 231 (11.3) w2(1) = 0.242, p = NS
Intermittent explosive disorder 28 (13.5) 24 (10.1) w2(1) = 1.226, p = NS
Kleptomania 6 (2.9) 8 (3.4) w2(1) = 0.083, p = NS
Trichotillomania (hair-pulling disorder) 14 (6.7) 9 (3.8) w2(1) = 1.976, p = NS
Non-suicidal self-injury 19 (9.1) 24 (10.1) w2(1) = 0.115, p = NS
Compulsive shopping 11 (5.3) 10 (4.2) w2(1) = 0.291, p = NS
Hypersexuality disorder 5 (2.4) 8 (3.4) w2(1) = 0.364, p = NS
Stereotypic movement disorder 2 of 199 (1) 3 of 227 (1.3) w2(1) = 0.092, p = NS
Borderline personality disorder 42 of 194 (21.6) 36 of 222 (16.2) w2(1) = 2.002, p = NS
Obsessive-compulsive personality disorder 80 of 197 (40.6) 34 of 223 (15.2) w2(1) = 34.592, p o 0.001
Avoidant personality disorder 36 of 194 (18.6) 33 of 222 (14.9) w2(1) = 1.018, p = NS
Schizotypal personality disorder 2 of 194 (1) 6 of 221 (2.7) w2(1) = 1.636, p = NS
Data presented as n (%).
NS = not significant; OCD = obsessive-compulsive disorder.
Table 4 Allele frequencies and genotype distribution of ANKK1 rs1800497 (DRD2 TaqI A polymorphism) in a Caucasian
subset of OCD patients with and without primary symmetry symptomatology
Allele frequencies Genotype distribution
n
A1
(T allele)
A2
(C allele) p-value
A1A1
(T/T)
A1A2
(T/C)
A2A2
(C/C) p-value
OCD with symmetry-related symptoms 116 35 (15.09) 197 (84.91) w2 = 4.1, 1 (0.41) 33 (13.52) 82 (33.61) w2 = 7.296,
OCD without symmetry-related symptoms 128 57 (22.27) 199 (77.73) p = 0.043 9 (3.69) 39 (15.98) 80 (32.79) p = 0.026
Data presented as n (%).
OCD = obsessive-compulsive disorder.
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1.2, depending on the disease allele frequencies, power
could vary greatly. In terms of ANKK1 rs1800497
specifically, power would range between 74 and 90%
for incidence rates of 36-50%, respectively. With a 46.5%
primary symmetry incidence rate in the current cohort, an
adequate percentage of 87% power was theorized. This
holds true for common polymorphisms of MAF X 0.2.27
Discussion
Just less than half of the study sample (46.6%) reported
primary symmetry-related obsessions and compulsions.
This is consistent with previous work, which has
described symmetry obsessions in 36 to 50% in adults
with OCD.28,29 OCD patients with primary symmetry-
related symptoms had significantly higher OCD severity
scores, longer illness duration, and increased psychiatric
comorbidity - but not increased childhood trauma or lower
level of functioning - compared to those without these
symptoms, suggesting that presence of primary symme-
try-related symptoms may represent a marker of severity
in OCD. Further work is needed to determine whether
similar relationships also hold in other psychiatric disorders,
such as body dysmorphic disorder (BDD), which are often
characterized by symmetry symptoms.30
Arguably, an attempt at a detailed analysis of the
relation between symmetry and any particular (comorbid)
disorder would be going beyond the data at hand.
Nevertheless, it is important to note that it is very common
for patients with OCD to present with other psychiatric
disorders. We found increased rates of OCPD in the
cohort with primary symmetry-related symptoms. This
condition is characterized by a chronic maladaptive
pattern of excessive perfectionism and a preoccupation
with orderliness and detail - traits which closely reflect the
so-called symmetry/ordering/counting/arranging symp-
tom dimension in OCD. We also observed a significant
association between primary symmetry symptomatology
and comorbid PTSD, an interesting finding given reports
of a link between stress and dopamine,14 as noted earlier.
In terms of psychobiological underpinnings, we expected
to find links between some of the selected dopaminergic
genes and symmetry in OCD, given the evidence from
some human and animal model studies. Specifically, one
study found a significant association between the symmetry
symptom dimension and the 2R allele of the DRD4 VNTR
polymorphism, subsequently suggesting that this symptom
dimension may represent a more homogeneous subtype of
OCD with a genetic etiology.31 This particular finding was
not replicated here. We found that the genotype frequency
of the ANKK1 rs1800497 polymorphism differed significantly
between the comparison groups, with more OCD patients
with symmetry symptoms being homozygous for the A2A2
(CC) genotype. ANKK1 rs1800497 is a restriction fragment
length polymorphism of DRD2, comprising two alleles,
which have historically been referred to as A1 (T allele)
and A2 (C allele).32-34
A number of studies have indicated that this single-
nucleotide polymorphism is associated with altered DRD2
Table 5 Associations of dopaminergic genes with symmetry
in OCD (excluding ANKK1 rs1800497)
Gene Polymorphism p-value
COMT rs4680 0.70
MAOA rs1137070 Males: 0.58
Females: 0.16
DAT 40bp VNTR 0.19
DRD1 rs4532 0.95
DRD3 rs6280 0.85
DRD4 48bp VNTR 0.65
bp = base pair; OCD = obsessive-compulsive disorder; VNTR =
variable number tandem repeat.
Table 6 Permutation correcting for multiple testing associated with multiallelic VNTR combinations
p-value
Gene Polymorphism Variable* Raw Permutation
DAT 40bp VNTR A9A9 0.172 0.510
A9A10 0.642 0.987
A10A10 0.826 0.999
A10A11 0.132 0.437
A9A11 0.254 0.729
A2A10 1 1
DRD4 48bp VNTR A7A7 0.334 0.944
A4A7 0.209 0.818
A4A4 0.315 0.904
A2A2 1 1
A2A4 1 1
A3A4 0.295 0.898
A3A3 1 1
A4A5 0.593 1
A4A6 0.629 1
A3A7 1 1
A5A5 1 1
A3A6 0.503 0.999
A2A7 1 1
VNTR = variable number tandem repeat.
*Variable refers to the allelic combination being assessed, where A is the designated allele and the subsequent numeric value is the number
of repeats of that allele.
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expression and has functional effects on dopamine
receptor density.35 Data from the HapMap project have
also suggested that the Taq1A variant is in linkage
disequilibrium with other variants in the DRD2 gene, but
not with variants in the ANKK1 gene.34 Since the A1
(ancestral) allele of the ANKK1 rs1800497 polymorphism
has been found to be associated with a variety of
addictive, impulsive, and compulsive disorders, such as
alcoholism, drug abuse, smoking, obesity, and compul-
sive gambling, as well as with several personality
disorders,36 the association of the A2A2 genotype and
A2 allele (the newly evolved variant) found herein was
arguably unexpected. On the other hand, the literature
has also emphasized that compulsive and impulsive
disorders may at times have divergent underlying
neurobiology. The new A2 variant is associated with
increased D2 density in the striatum. (Speculatively, the
new A2 variant is associated with greater reward from
symmetry-related stimuli, while the ancient A1 variant is
associated with greater reward from impulsive behaviors;
further work is needed, however, to understand the
functional psychobiology of gene variants in ANKK1
rs1800497.)
To our knowledge, only three previous studies have
examined the association between the DRD2 TaqI A
system and OCD, and none of those found a significant
association with OCD in general.37-39 However, two of
those studies found an association with a subgroup of
OCD patients, i.e., OCD with tics, and OCD with an early
age of onset: Nicolini et al.38,39 observed a higher
frequency of the ANKK1 rs1800497 A2 alleles and more
individuals homozygous for A2A2 in a subgroup with
comorbid tics; Denys et al.40 found an association
between the A2A2 genotype in patients with an early
onset of OCD, and when their sample was stratified by
gender, there was a trend towards significance for the
A2A2 genotype (p = 0.049), and a higher frequency of the
A2 alleles in male OCD patients compared to male
controls. There is certainly a relationship between the tic
subtype of OCD, early onset of OCD, and symmetry
symptoms, as demonstrated by our findings. Thus, it is
also possible that the ANKK1 rs1800497 (new) variant is
associated with risk of this phenotype – perhaps reflecting
increased striatal dopaminergic activity.
Considering the link between symmetry symptoms and
OCD severity noted earlier, and that human and animal
studies both confirm the involvement of dopamine
circuitry in OCD, it is interesting that treatment-resistant
OCD specifically may exhibit improved response following
adjunctive treatment with a D2 receptor antagonist.
41 The
above-mentioned relationship between primary symmetry
symptomatology and comorbid PTSD may also have a
connection with dopamine, especially since altered
dopaminergic activity has been suggested to compromise
the ability to develop effective coping strategies following
aversive situations in an animal model.42
Several limitations should be acknowledged. Other
genetic variants, or interactions with others, may play a
role. These findings should be considered preliminary, as
the numbers of patients for whom we had genetic data
were small, resulting in relatively little power to detect
group differences. In addition, future investigations should
take into account epigenetic effects, which impact the
expression of genes without altering the primary DNA
sequence. Indeed, a potentially complementary line of
research implicates DRD2 in gene-environment correla-
tions and interactions, in addition to its influence on the
way in which symptoms present.43 Nevertheless, one
strength is that this was the first study to examine both the
demographic/clinical and genetic correlates of primary
symmetry symptomatology in OCD.
In conclusion, our findings replicate previous studies that
suggested that symmetry symptoms are very common in
OCD, have some distinct clinical features, and may
represent a marker of OCD severity. However, the clinical
associations observed, in combination with the significant
association found with the DRD2/ANKK1 rs1800497 A2
polymorphism, suggest that primary symmetry obsessions
and related compulsions may also represent a distinctive
clinical and psychobiological profile in OCD. These are
important findings, and may have clinical utility. Follow-up
of associations between symmetry symptoms in OCD and
functional gene variants in the dopaminergic system (and
other possibly involved systems, e.g., the serotonergic
and glutamatergic systems), in a larger sample to increase
statistical power, is warranted.
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